WALTHAM, Mass., Sept. 4, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders, announced today that Dr. Paul Sohmer, BG Medicine's President and CEO, will be presenting at the Baird 2013 Health Care Conference on September 10, 2013, at The New York Palace, beginning at 2:20 PM Eastern Time (ET).
Audio and slides of BG Medicine's presentation will be webcast at: http://wsw.com/webcast/baird35/BGMD. The webcast will be archived for 30 days following the live presentation on BG Medicine's Investor Relations website at ir.BG-medicine.com.
About BG Medicine
BG Medicine, Inc. (Nasdaq:BGMD) is a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit www.BG-medicine.com and www.galectin-3.com. The BG Medicine Inc. logo is available for download here
CONTACT: Chuck Abdalian
EVP & Chief Financial Officer
(781) 434-0210
